Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy

Lignende værker

• Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer
  af: Agus Andreas Santoso, et al.
  Udgivet: (2025-05-01)
• The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells
  af: Zhou, Yan, et al.
  Udgivet: (2015)
• Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
  af: Scagliotti, Giorgio, et al.
  Udgivet: (2010)
• Management of non-small cell lung cancer with EGFR mutation: the role of radiotherapy in the era of tyrosine kinase inhibitor therapy—opportunities and challenges
  af: Xia, Bing, et al.
  Udgivet: (2017)
• Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis
  af: Zhang, Zhonghan, et al.
  Udgivet: (2019)